Clinical trials
Phase 4 trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Terminated | 5 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 10 |
| Hoffmann-La Roche | 10 |
| Novartis Pharmaceuticals | 7 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 |
| Abbott Medical Devices | 2 |
| Bayer | 2 |
| Biotronik SE & Co. KG | 2 |
| Bristol-Myers Squibb | 2 |
| Novo Nordisk A/S | 2 |
| Pauls Stradins Clinical University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 8 |
| Coronary Artery Disease | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Heart Failure | 4 |
| Diabetes Mellitus | 3 |
| HIV Infections | 3 |
| Angina Pectoris | 2 |
| Arthritis, Rheumatoid | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.